Idorsia Ltd. (IDRSF)
5.38
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
Idorsia Total Long Term Debt (Quarterly) : 1.347B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.347B |
| March 31, 2026 | 1.661B |
| December 31, 2025 | 1.621B |
| September 30, 2025 | 1.560B |
| June 30, 2025 | 1.372B |
| March 31, 2025 | 1.181B |
| December 31, 2024 | 1.156B |
| September 30, 2024 | 1.050B |
| June 30, 2024 | 1.172B |
| March 31, 2024 | 1.168B |
| December 31, 2023 | 1.185B |
| September 30, 2023 | 1.092B |
| June 30, 2023 | 1.342B |
| March 31, 2023 | 1.331B |
| December 31, 2022 | 1.317B |
| September 30, 2022 | 1.207B |
| June 30, 2022 | 1.245B |
| March 31, 2022 | 1.291B |
| December 31, 2021 | 1.266B |
| Date | Value |
|---|---|
| September 30, 2021 | 1.334B |
| June 30, 2021 | 681.59M |
| March 31, 2021 | 669.63M |
| December 31, 2020 | 713.24M |
| September 30, 2020 | 682.49M |
| June 30, 2020 | 660.77M |
| March 31, 2020 | 646.57M |
| December 31, 2019 | 655.33M |
| September 30, 2019 | 633.34M |
| June 30, 2019 | 646.54M |
| March 31, 2019 | 626.49M |
| December 31, 2018 | 592.25M |
| September 30, 2018 | 582.32M |
| June 30, 2018 | 371.11M |
| March 31, 2018 | 382.81M |
| December 31, 2017 | 374.23M |
| September 30, 2017 | 374.91M |
| June 30, 2017 | 376.92M |
| March 31, 2017 | 296.61M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | 0.00 |
| Santhera Pharmaceuticals Holding AG | 0.00 |
| BeOne Medicines Ltd. | 1.808B |
| AC Immune SA | 5.085M |
| CRISPR Therapeutics AG | 765.10M |